Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stian Foss

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Iscience|February 4, 2022
Antibody variable sequences have a pronounced effect on cellular transport and plasma half-lifeAlgirdas Grevys, Rahel Frick, Simone Mester, et al.
Immunobiology|December 4, 2014
Eculizumab treatment during pregnancy does not affect the complement system activity of the newbornRandi Fykse Hallstensen, Grethe Bergseth, Stian Foss, et al.
Nature Communications|May 30, 2023
Antibody blockade of Jagged1 attenuates choroidal neovascularizationTorleif Tollefsrud Gjølberg, Jonas Aakre Wik, Hanna Johannessen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2018
TRIM21 mediates antibody inhibition of adenovirus-based gene delivery and vaccinationMaria Bottermann, Stian Foss, Laurens M van Tienen, et al.
Nature Communications|February 14, 2018
A human endothelial cell-based recycling assay for screening of FcRn targeted moleculesAlgirdas Grevys, Jeannette Nilsen, Kine M K Sand, et al.
Cell Host & Microbe|March 31, 2019
Complement C4 Prevents Viral Infection through Capsid InactivationMaria Bottermann, Stian Foss, Sarah L Caddy, et al.
Frontiers in Immunology|June 22, 2023
Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cellsMarta Lustig, Chilam Chan, J H Marco Jansen, et al.
PNAS Nexus|March 5, 2025
Engineering of anticancer human immunoglobulin A equipped with albumin for enhanced plasma half-lifeSimone Mester, Chilam Chan, Marta Lustig, et al.
Cell Systems|November 13, 2025
Systematic benchmarking of mass spectrometry-based antibody sequencing reveals methodological biasesMaria Chernigovskaya, Khang Lê Quý, Maria Stensland, et al.
The Journal of Experimental Medicine|July 14, 2020
FcRn is a CD32a coreceptor that determines susceptibility to IgG immune complex-driven autoimmunityJonathan J Hubbard, Michal Pyzik, Timo Rath, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Iscience|February 4, 2022
Antibody variable sequences have a pronounced effect on cellular transport and plasma half-lifeAlgirdas Grevys, Rahel Frick, Simone Mester, et al.
Immunobiology|December 4, 2014
Eculizumab treatment during pregnancy does not affect the complement system activity of the newbornRandi Fykse Hallstensen, Grethe Bergseth, Stian Foss, et al.
Nature Communications|May 30, 2023
Antibody blockade of Jagged1 attenuates choroidal neovascularizationTorleif Tollefsrud Gjølberg, Jonas Aakre Wik, Hanna Johannessen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2018
TRIM21 mediates antibody inhibition of adenovirus-based gene delivery and vaccinationMaria Bottermann, Stian Foss, Laurens M van Tienen, et al.
Nature Communications|February 14, 2018
A human endothelial cell-based recycling assay for screening of FcRn targeted moleculesAlgirdas Grevys, Jeannette Nilsen, Kine M K Sand, et al.
Cell Host & Microbe|March 31, 2019
Complement C4 Prevents Viral Infection through Capsid InactivationMaria Bottermann, Stian Foss, Sarah L Caddy, et al.
Frontiers in Immunology|June 22, 2023
Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cellsMarta Lustig, Chilam Chan, J H Marco Jansen, et al.
PNAS Nexus|March 5, 2025
Engineering of anticancer human immunoglobulin A equipped with albumin for enhanced plasma half-lifeSimone Mester, Chilam Chan, Marta Lustig, et al.
Cell Systems|November 13, 2025
Systematic benchmarking of mass spectrometry-based antibody sequencing reveals methodological biasesMaria Chernigovskaya, Khang Lê Quý, Maria Stensland, et al.
The Journal of Experimental Medicine|July 14, 2020
FcRn is a CD32a coreceptor that determines susceptibility to IgG immune complex-driven autoimmunityJonathan J Hubbard, Michal Pyzik, Timo Rath, et al.
Pageof 4